Gluteal nodules in patients with metastatic midgut carcinoid disease treated with depot somatostatin analogs

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 5, 2008, Pages 1860-1864

  Debono, Miguel ^a   Hon, Lye Quen ^a   Bax, Nigel ^a   Blakeborough, Anthony ^a   Newell Price, John ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

ABDOMINAL RADIOGRAPHY; ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENDOCRINE TUMOR; FEMALE; GLUTEUS MAXIMUS MUSCLE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDGUT CARCINOID; PRIORITY JOURNAL; SMALL INTESTINE TUMOR; SUBCUTANEOUS NODULE; TREATMENT DURATION;

EID: 43249122859     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0019     Document Type: Article

References (15)

1. GA Kaltsas GM Besser AB Grossman The diagnosis and medical management of advanced neuroendocrine tumors Endocr Rev 25 2004 458 511
2. PF Quaedvlieg O Visser CB Lamers ML Janssen-Heijen BG Taal Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients Ann Oncol 12 2001 1295 1300
3. KO Shebani WW Souba DM Finkelstein PC Stark KM Elgadi KK Tanabe MJ Ott Prognosis and survival in patients with gastrointestinal tract carcinoid tumors Ann Surg 229 1999 815 821 discussion 822-823
4. ET Janson L Holmberg M Stridsberg B Eriksson E Theodorsson E Wilander K Oberg Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center Ann Oncol 8 1997 685 690
5. J Rubin J Ajani W Schirmer AP Venook R Bukowski R Pommier L Saltz P Dandona L Anthony Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome J Clin Oncol 17 1999 600 606
6. J Garland JR Buscombe C Bouvier P Bouloux MH Chapman AC Chow N Reynolds ME Caplin Sandostatin LAR (long-acting octreotide acetate) for malignant carcinoid syndrome: a 3-year experience Aliment Pharmacol Ther 17 2003 437 444
7. P Ruszniewski S Ish-Shalom M Wymenga D O'Toole R Arnold P Tomassetti N Bax M Caplin B Eriksson B Glaser M Ducreux C Lombard-Bohas WW de Herder G Delle Fave N Reed JF Seitz E Van Cutsem A Grossman P Rougier W Schmidt B Wiedenmann Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide Neuroendocrinology 80 2004 244 251
8. S Ricci A Antonuzzo L Galli M Ferdeghini L Bodei C Orlandini PF Conte Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide Ann Oncol 11 2000 1127 1130
9. R Arnold ME Trautmann W Creutzfeldt R Benning M Benning C Neuhaus R Jurgensen K Stein H Schafer C Bruns HJ Dennler Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours Gut 38 1996 430 438
10. JK Ramage AH Davies J Ardill N Bax M Caplin A Grossman R Hawkins AM McNicol N Reed R Sutton R Thakker S Aylwin D Breen K Britton K Buchanan P Corrie A Gillams V Lewington D McCance K Meeran A Watkinson Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours Gut 54 Suppl 4 2005 iv1 iv16
11. JM Zuetenhorst ML van Velthuysen EJ Rutgers H Boot BC Taal Pathogenesis and treatment of pain caused by skin metastases in neuroendocrine tumours Neth J Med 60 2002 207 211
12. K Oberg L Kvols M Caplin G Delle Fave W de Herder G Rindi P Ruszniewski EA Woltering B Wiedenmann Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system Ann Oncol 15 2004 966 973
13. FG Que DM Nagorney KP Batts LJ Linz LK Kvols Hepatic resection for metastatic neuroendocrine carcinomas Am J Surg 169 1995 36 42 discussion 42-33
14. P Caron M Cogne I Raingeard V Bex-Bachellerie JM Kuhn Effectiveness and tolerability of 3-year lanreotide Autogel treatment in patients with acromegaly Clin Endocrinol (Oxf) 64 2006 209 214
15. DJ Rideout MM Graham Buttock granulomas: a consequence of intramuscular injection of Sandostatin detected by In-111 octreoscan Clin Nucl Med 26 2001 650